# Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens

> **NCT01854099** · PHASE1 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Glioblastoma

## Interventions

- **BIOLOGICAL:** PEP-CMV
- **BIOLOGICAL:** PEP-CMV
- **BIOLOGICAL:** PEP-CMV

## Key facts

- **NCT ID:** NCT01854099
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator decided not to open study.
- **Last updated:** 2014-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854099, "Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01854099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*